HHS, DARPA link up with Rutgers, Cost Plus Drugs and others in initiative to rethink US drug production
In a new public-private partnership, the Department of Health and Human Services and DARPA are linking up with several universities and companies in a bid to improve manufacturing for essential medicines in the U.S. using artificial intelligence, machine learning and informatics.
In a new public-private partnership, the Department of Health and Human Services and DARPA are linking up with several universities and companies in a bid to improve manufacturing for essential medicines in the U.S. using artificial intelligence, machine learning and informatics.
